Cargando…

Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer

Prostate specific membrane antigen (PSMA) is a marker for diagnosis and targeted delivery of therapeutics to advanced/metastasized prostate cancer. We report a liposome-based system for theranostic delivery to PSMA-expressing (PSMA(+)) LNCaP cells. A lipopolymer (P(3)) comprising of PSMA ligand (PSM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yari, Hooman, Nkepang, Gregory, Awasthi, Vibhudutta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427334/ https://www.ncbi.nlm.nih.gov/pubmed/30841602 http://dx.doi.org/10.3390/ma12050756

Ejemplares similares

Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes
por: Mare, Rosario, et al.
Publicado: (2019)

Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method
por: Raghuvanshi, Dhawal, et al.
Publicado: (2017)

Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome
por: Rao, Geeta, et al.
Publicado: (2018)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Surface Engineering of Liposomes for Stealth Behavior
por: Nag, Okhil K., et al.
Publicado: (2013)

Hybrid lipopolymer vesicle drug delivery and release systems
por: Reimhult, Erik, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)

Structure and dynamics of liposomes designed for drug delivery: coarse-grained molecular dynamics simulations to reveal the role of lipopolymer incorporation
por: Lemaalem, Mohammed, et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen Expression in Meningioma: A Promising Theranostic Target
por: Tubre, Teddi, et al.
Publicado: (2022)

Synthesis and Properties of Low-Molecular-Weight PEI-Based Lipopolymers for Delivery of DNA
por: Xun, Miao-Miao, et al.
Publicado: (2018)

Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers
por: Wang, Huijing, et al.
Publicado: (2023)

Physisorbed Polymer-Tethered Lipid Bilayer with Lipopolymer Gradient
por: Lin, Yu-Hung, et al.
Publicado: (2012)

Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent
por: Chatalic, Kristell L.S., et al.
Publicado: (2016)

Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
por: Ranjan, Satish Kumar
Publicado: (2020)

Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations
por: Burgard, Caroline, et al.
Publicado: (2023)

Prostate-specific Membrane Antigen Imaging in Recurrent Medullary Thyroid Cancer: A New Theranostic Tracer in the Offing?
por: Arora, Saurabh, et al.
Publicado: (2018)

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma
por: Giraudet, Anne Laure, et al.
Publicado: (2023)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Theranostic Liposome–Nanoparticle Hybrids for Drug Delivery and Bioimaging
por: Seleci, Muharrem, et al.
Publicado: (2017)

Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA
por: Temprana, C. Facundo, et al.
Publicado: (2017)

Liposomes for Cancer Theranostics
por: Fernandes, Donald A.
Publicado: (2023)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Prostate-specific membrane antigen-mediated theragnostics in prostate cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2021)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
por: Chen, Yang, et al.
Publicado: (2022)

PSMA-GCK01: A Generator-Based (99m)Tc/(188)Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
por: Cardinale, Jens, et al.
Publicado: (2023)

Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen
por: Dassie, Justin P, et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen-Based Therapeutics
por: Akhtar, Naveed H., et al.
Publicado: (2012)

Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
por: Awasthi, Vibhudutta, et al.
Publicado: (2021)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Advanced nanomaterial for prostate cancer theranostics
por: Hao, Bin, et al.
Publicado: (2022)

Incidental prostate-specific membrane antigen-avid meningioma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2021)

Incidental prostate-specific membrane antigen-avid glioblastoma detected on (68)Ga–prostate-specific membrane antigen PET/CT
por: Jiang, James Yuheng, et al.
Publicado: (2022)

Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity
por: Vit, Ondrej, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen PET Imaging in Prostate Cancer: Opportunities and Challenges
por: Oh, So Won, et al.
Publicado: (2018)

Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer
por: Rosenfeld, Lior, et al.
Publicado: (2020)

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
por: Paschalis, Alec, et al.
Publicado: (2019)

Prostate-specific membrane antigen is undetectable in choroidal neovascular membrane
por: Godeiro, Katyanne Dantas, et al.
Publicado: (2006)

Tobacco mosaic virus for the targeted delivery of drugs to cells expressing prostate-specific membrane antigen
por: Shukla, Sourabh, et al.
Publicado: (2021)

Development of Theranostic Cationic Liposomes Designed for Image-Guided Delivery of Nucleic Acid
por: Do, Hai Doan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qse8fnbi5qqsr8f99b3r6vetd4